Drug-drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug-drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition

Published:2010-11-14 Issue:6 Volume:268 Page:530-539
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:

Author:

Josephson F.

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2796.2010.02301.x/fullpdf

Reference58 articles.

1. European SPC Sustiva. Bristol-Myers Squibb 2010 http://www.ema.europa.eu/humandocs/Humans/EPAR/sustiva/sustiva.htm

2. European SPC Viramune. Boehringer Ingelheim 2009 http://www.ema.europa.eu/humandocs/Humans/EPAR/viramune/viramune.htm

3. European SPC Intelence. Janssen-Cilag 2010 http://www.ema.europa.eu/humandocs/Humans/EPAR/intelence/intelence.htm

4. European SPC Kaletra. Abbott Laboratories 2010 http://www.ema.europa.eu/humandocs/Humans/EPAR/kaletra/kaletra.htm

5. European SPC Prezista. Janssen-Cilag 2010 http://www.ema.europa.eu/humandocs/Humans/EPAR/prezista/prezista.htm

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intranasal delivery of darunavir improves brain drug concentrations in mice for effective HIV treatment;Biochemistry and Biophysics Reports;2023-03

2. Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury;Frontiers in Pharmacology;2022-10-20

3. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters;mBio;2022-04-26

4. Clinically relevant enantiomer specific R‐ and S‐praziquantel pharmacokinetic drug‐drug interactions with efavirenz and ritonavir;Pharmacology Research & Perspectives;2021-04-30

5. Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition;Drug Metabolism Reviews;2021-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3